Literature DB >> 842353

Ultrastructural studies on the endogenous development of eimeria brunetti. III. Macrogametogony and the macrogamete.

D J Ferguson, A Birch-Andersen, W M Hutchison, J C Siim.   

Abstract

The ultrastructural changes occurring during macrogametogony in Eimeria brunetti were studied in tissue from the small intestine of infected young domestic fowls. As the macrogametocyte developed, an increase in the volume of the cytoplasm and the nucleus occurred. At this early stage of development the organism was limited by a single unit membrane which possessed a number of micropores. The organism was situated in a parasitophorous vacuole which contained intra-vacuolar folds and intra-vacuolar tubules. The wall forming bodies of type II (WFB II) started to appear before the wall forming bodies of Type I (WFB I). The WFB I developed in the cytoplasmic matric whereas the WFB II were formed within the cisternae of the rough endoplasmic reticulum apparently in association with Golgi bodies. The mature WFB I were homogeneous, limited by a unit membrane, and larger than WFB II which had no limiting membrane but remained surrounded by a membrane of the rough endoplasmic reticulum. Polysaccharide granules were formed in the cytoplasm between strands of the rough endoplasmic reticulum. During maturation the WFB I & II and the polysaccharide granules increased in size and number, and as this occurred a number of electron translucent vacuoles were ejected from the surface of the macrogametocyte. The mature macrogamete possessed a large nucleus with a nucleolus, a number of multi-membranous vacuoles, mitochondria, and canaliculi. The WFB I & II were located at the cell periphery and the polysaccharide granules further towards the interior of the organism. The organism was limited by a unit membrane but during macrogametogony a homogeneous layer had developed which extensively coated the macrog...

Entities:  

Mesh:

Year:  1977        PMID: 842353     DOI: 10.1111/j.1699-0463.1977.tb01677.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand B        ISSN: 0105-0656


  7 in total

1.  Maternal inheritance and stage-specific variation of the apicoplast in Toxoplasma gondii during development in the intermediate and definitive host.

Authors:  David J P Ferguson; Fiona L Henriquez; Michael J Kirisits; Stephen P Muench; Sean T Prigge; David W Rice; Craig W Roberts; Rima L McLeod
Journal:  Eukaryot Cell       Date:  2005-04

2.  The ultrastructural development of the macrogamete of Eimeria stiedai.

Authors:  R M Pittilo; S J Ball; W M Hutchison
Journal:  Protoplasma       Date:  1980       Impact factor: 3.356

3.  Ultrastructural evaluation of the effects of diclazuril on the endogenous stages of Eimeria maxima and E. brunetti in experimentally inoculated chickens.

Authors:  A Verheyen; L Maes; W Coussement; O Vanparijs; F Lauwers; E Vlaminckx; R Marsboom
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

4.  Ultrastructural effects of acetamizuril on endogenous phases of Eimeria tenella.

Authors:  Lili Liu; Huiya Chen; Chenzhong Fei; Xiaoyang Wang; Wenli Zheng; Mi Wang; Keyu Zhang; Lifang Zhang; Tao Li; Feiqun Xue
Journal:  Parasitol Res       Date:  2015-12-28       Impact factor: 2.289

5.  MORN1 has a conserved role in asexual and sexual development across the apicomplexa.

Authors:  David J P Ferguson; Nivedita Sahoo; Robert A Pinches; Janene M Bumstead; Fiona M Tomley; Marc-Jan Gubbels
Journal:  Eukaryot Cell       Date:  2008-02-29

6.  Comparison of protective immune responses to apicomplexan parasites.

Authors:  Sonja Frölich; Rolf Entzeroth; Michael Wallach
Journal:  J Parasitol Res       Date:  2011-08-18

7.  Identification and analysis of Eimeria nieschulzi gametocyte genes reveal splicing events of gam genes and conserved motifs in the wall-forming proteins within the genus Eimeria (Coccidia, Apicomplexa).

Authors:  Stefanie Wiedmer; Alexander Erdbeer; Beate Volke; Stephanie Randel; Franz Kapplusch; Sacha Hanig; Michael Kurth
Journal:  Parasite       Date:  2017-12-06       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.